These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 36434521)
1. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis. Muchadeyi MT; Hernandez-Villafuerte K; Schlander M BMC Med Res Methodol; 2022 Nov; 22(1):303. PubMed ID: 36434521 [TBL] [Abstract][Full Text] [Related]
2. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations. Muchadeyi MT; Hernandez-Villafuerte K; Di Tanna GL; Eckford RD; Feng Y; Meregaglia M; Peasgood T; Petrou S; Ubels J; Schlander M Pharmacoeconomics; 2024 Jul; 42(7):767-782. PubMed ID: 38551803 [TBL] [Abstract][Full Text] [Related]
3. A systematic literature review of health state utility values in head and neck cancer. Meregaglia M; Cairns J Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Health state utility values among children and adolescents with disabilities: protocol for a systematic review. Kanya L; Anokye N; Ryan JM BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137 [TBL] [Abstract][Full Text] [Related]
6. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses. Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177 [TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results. Han R; François C; Toumi M Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846 [TBL] [Abstract][Full Text] [Related]
8. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB). Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030 [TBL] [Abstract][Full Text] [Related]
9. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression. Wang Y; Gavan SP; Steinke D; Cheung KL; Chen LC Health Qual Life Outcomes; 2022 Dec; 20(1):169. PubMed ID: 36564800 [TBL] [Abstract][Full Text] [Related]
10. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients. Paracha N; Abdulla A; MacGilchrist KS Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899 [TBL] [Abstract][Full Text] [Related]
11. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review. Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649 [TBL] [Abstract][Full Text] [Related]
12. Cost-utility analyses of drug therapies in breast cancer: a systematic review. Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551 [TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
14. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. Meregaglia M; Nicod E; Drummond M Eur J Health Econ; 2023 Sep; 24(7):1151-1216. PubMed ID: 36335234 [TBL] [Abstract][Full Text] [Related]
15. Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression. Wang Y; Xu Y; Shan H; Pan H; Chen J; Yang J Health Qual Life Outcomes; 2024 Sep; 22(1):74. PubMed ID: 39244536 [TBL] [Abstract][Full Text] [Related]
16. Health state utility values by cancer stage: a systematic literature review. Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315 [TBL] [Abstract][Full Text] [Related]
17. Inter-reviewer reliability of human literature reviewing and implications for the introduction of machine-assisted systematic reviews: a mixed-methods review. Hanegraaf P; Wondimu A; Mosselman JJ; de Jong R; Abogunrin S; Queiros L; Lane M; Postma MJ; Boersma C; van der Schans J BMJ Open; 2024 Mar; 14(3):e076912. PubMed ID: 38508610 [TBL] [Abstract][Full Text] [Related]
18. A systematic review of health state utility values and psychometric performance of generic preference-based instruments for children and adolescents with mental health problems. Thai TTH; Engel L; Perez JK; Tan EJ; Eades S; Sanci L; Mihalopoulos C Qual Life Res; 2023 Nov; 32(11):3005-3026. PubMed ID: 37237136 [TBL] [Abstract][Full Text] [Related]
19. Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany. Dreier M; Borutta B; Stahmeyer J; Krauth C; Walter U GMS Health Technol Assess; 2010 Jun; 6():Doc07. PubMed ID: 21289880 [TBL] [Abstract][Full Text] [Related]